Effects of low dose quercetin: Cancer cell-specific inhibition of cell cycle progression

Journal of Cellular Biochemistry

Volumn 106, Issue 1, 2009, Pages 73-82

  Jeong, Jae Hoon ^a,b   An, Jee Young ^c   Kwon, Yong Tae ^c   Rhee, Juong G ^d   Lee, Yong J ^b,e  

^a Inha University   (South Korea)

^b UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF PITTSBURGH   (United States)

^d UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^e UNIVERSITY OF PITTSBURGH CANCER INSTITUTE   (United States)

Author keywords

Cell cycle; Chk2; Cyclin B1; Dna damage; P21; Quercetin

Indexed keywords

CHECKPOINT KINASE 2; CYCLIN B1; CYCLIN DEPENDENT KINASE 1; NUCLEAR FACTOR Y; PROTEIN P21; QUERCETIN; RETINOBLASTOMA PROTEIN; TRANSCRIPTION FACTOR E2F1;

ARTICLE; BREAST CANCER; CANCER CELL; CELL CYCLE ARREST; CELL CYCLE G1 PHASE; CELL CYCLE G2 PHASE; CELL CYCLE M PHASE; CELL CYCLE PROGRESSION; CELL CYCLE S PHASE; CELL PROLIFERATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOTOXICITY; DNA DAMAGE; DOWN REGULATION; DRUG EFFECT; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN INDUCTION; PROTEIN PHOSPHORYLATION;

ANTICARCINOGENIC AGENTS; ANTIOXIDANTS; CDC2 PROTEIN KINASE; CELL CYCLE; CELL PROLIFERATION; CYCLIN B; CYCLIN-DEPENDENT KINASE INHIBITOR P21; DNA DAMAGE; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; PROTEIN-SERINE-THREONINE KINASES; QUERCETIN; TRANSCRIPTION, GENETIC; TUMOR CELLS, CULTURED;

EID: 58649083936     PISSN: 07302312     EISSN: 10974644     Source Type: Journal    
DOI: 10.1002/jcb.21977     Document Type: Article

References (46)

1. Aliouat-Denis CM, Dendouga N, Van den Wyngaert I, Goehlmann H, Steller U, van de Weyer I, Van Slycken N, Andries L, Kass S, Luyten W, Janicot M, Vialard JE. 2005. p53-independent regulation of p21Waf1/Cip1 expression and senescence by Chk2. Mol Cancer Res 3:627-634.
2. Beniston RG, Campo MS. 2003. Quercetin elevates p27(Kip1) and arrests both primary and HPV16 E6/E7 transformed human keratinocytes in G1. Oncogene 22:5504-5514.
3. Block G, Patterson B, Subar A. 1992. Fruit, vegetables, and cancer prevention: A review of the epidemiological evidence. Nutr Cancer 18:1-29.
4. Bors W, Heller W, Michel C, Saran M. 1990. Flavonoids as antioxidants: Determination of radical-scavenging efficiencies. Methods Enzymol 186: 343-355.
5. Bors W, Michel C, Saran M. 1994. Flavonoid antioxidants: Rate constants for reactions with oxygen radicals. Methods Enzymol 234:420-429.
6. Burow ME, Weldon CB, Tang Y, Navar GL, Krajewski S, Reed JC, Hammond TG, Clejan S, Beckman BS. 1998. Differences in susceptibility to tumor necrosis factor alpha-induced apoptosis among MCF-7 breast cancer cell variants. Cancer Res 58:4940-4946.
7. Choi JA, Kim JY, Lee JY, Kang CM, Kwon HJ, Yoo YD, Kim TW, Lee YS, Lee SJ. 2001. Induction of cell cycle arrest and apoptosis in human breast cancer cells by quercetin. Int J Oncol 19:837-844.
8. da Silva EL, Piskula MK, Yamamoto N, Moon JH, Terao J. 1998. Quercetin metabolites inhibit copper ion-induced lipid peroxidation in rat plasma. FEBS Lett 430:405-408.
9. Di Carlo G, Mascolo N, Izzo AA, Capasso F. 1999. Flavonoids: Old and new aspects of a class of natural therapeutic drugs. Life Sci 65:337-353.
10. el-Deiry W, Tokino T, Velculescu VE, Levy DB, Parsons R, Trent JM, Liis D, Mercer WE, Kinzler KW, Vogelstein B. 1993. WAFJ, a potential mediator of p53 tumor suppression. Cell 75:817-825.
11. Gugler R, Leschik M, Dengler HJ. 1975. Disposition of quercetin in man after single oral and intravenous doses. Eur J Clin Pharmacol 9:229-234.
12. Harper JW, Adami GR, Wei N, Keyomarsi K, Elledge SJ. 1993. The p21 Cdkinteracting protein Cipl is a potent inhibitor of Gi cyclin-dependent kinases. Cell 75:805-816.
13. Hertog MG, Hollman PC, Katan MB, Kromhout D. 1993. Intake of potentially anti-carcinogenic flavonoids and their determinants in adults in The Netherlands. Nutr Cancer 20:21-29.
14. Hollman PC, van Trijp JM, Buysman MN, van der Gaag MS, Mengelers MJ, de Vries JH, Katan MB. 1997. Relative bioavailability of the anti-oxidant flavonoid quercetin from various foods in man. FEBS Lett 418:152-156.
15. Holmgren A. 1989. Thioredoxin and glutaredoxin systems. J Biol Chem 264: 13963-13966.
16. Kandaswami C, Middleton E, Jr. 1994. Free radical scavenging and antioxidant activity of plant flavonoids. Adv Exp Med Biol 366:351-376.
17. Kastan MB, Lim DS. 2000. The many substrates and functions of ATM. Nat Rev Mol Cell Biol 1:179-186.
18. Kim YH, Lee DH, Jeong JH, Guo ZS, Lee YJ. 2008. Quercetin augments TRAIL-induced apoptotic death: Involvement of the ERK signal transduction pathway. Biochem Pharmacol 75:1946-1958.
19. Kuhnau J. 1976. The flavonoids. A class of semi-essential food components: Their role in human nutrition. World Rev Nutr Diet 24:117-191.
20. Lea MA, Xiao Q, Sadhukhan AK, Cottle S, Wang ZY, Yang CS. 1993. Inhibitory effects of tea extracts and (-)-epigallocatechin gallate on DNA synthesis and proliferation of hepatoma and erythroleukemia cells. Cancer Lett 68:231-236.
21. Lee TJ, Kim OH, Kim YH, Lim JH, Kim S, Park JW, Kwon TK. 2006. Quercetinarrests G2/M phase and induces caspase-dependent cell death in U937 cells. Cancer Lett 240:234-242.
22. Matsuoka S, Rotman G, Ogawa A, Shiloh Y, Tamai K, Elledge SJ. 2000. Ataxia telangiectasia-mutated phosphorylates Chk2 in vivo and in vitro. Proc Natl Acad Sci USA 97:10389-10394.
23. Melchionna R, Chen XB, Blasina A, McGowan CH. 2000. Threonine 68 is required for radiation-induced phosphorylation and activation of Cds1. Nat Cell Biol 2:762-765.
24. Menssen A, Hermeking H. 2002. Characterization of the c-MYC-regulated transcriptome by SAGE: Identification and analysis of c-MYC target genes. Proc Natl Acad Sci USA 99:6274-6279.
25. Metodiewa D, Jaiswal AK, Cenas N, Dickancaite E, Segura-Aguilar J. 1999. Quercetin may act as a cytotoxic prooxidant after its metabolic activation to semiquinone and quinoidal product. Free Radic Biol Med 26:107-116.
26. Molinari M. 2000. Cell cycle checkpoints and their inactivation in human cancer. Cell Prolif 33:261-274.
27. Nielsen SE, Kall M, Justesen U, Schou A, Dragsted LO. 1997. Human absorption and excretion of flavonoids after broccoli consumption. Cancer Lett 114:173-174.
28. Oberley LW, Buettner GR. 1979. Role of superoxide dismutase in cancer: A review. Cancer Res 39:1141-1149.
29. Ong CS, Tran E, Nguyen TT, Ong CK, Lee SK, Lee JJ, Ng CP, Leong C, Huynh H. 2004. Quercetin-induced growth inhibition and cell death in nasopharyngeal carcinoma cells are associated with increase in Bad and hypophosphorylated retinoblastoma expressions. Oncol Rep 11:727-733.
30. Padilla CA, Martinez-Galiseo E, Barcena JA, Spyrou G, Holmgren A. 1995. Purification from placenta, amino acid sequence, structure comparisons, and cDNA cloning of human glutaredoxin. Eur J Biochem 227:27-34.
31. Plaumann B, Fritsche M, Rimpler H, Brandner G, Hess RD. 1996. Flavonoids activate wild-type p53. Oncogene 13:1605-1614.
32. Rogakou EP, Boon C, Redon C, Bonner WM. 1999. Megabase chromatin domains involved in DNA double-strand breaks in vivo. J Cell Biol 146:905-916.
33. Rogakou EP, Nieves-Neira W, Boon C, Pommier Y, Bonner WM. 2000. Initiation of DNA fragmentation during apoptosis induces phosphorylation of H2A.X histone at serine 139. J Biol Chem 275:9390-9395.
34. Saitoh M, Nishitoh H, Fujii M, Takeda K, Tobiume K, Sawada Y, Kawabata M, Miyazono K, Ichijo H. 1998. Mammalian thioredoxin is a direct inhibitor of apoptosis signal-regulating kinase (ASK) 1. EMBO J 17:2596-2606.
35. Schafer KA. 1998. The cell cycle: A review. Vet Pathol 35:461-478.
36. Sherr CJ. 1996. Cancer cell cycles. Science 274:1672-1677.
37. 2. J Biol Chem 277:46566-46575.
38. Soule HD, Maloney TM, Wolman SR, Peterson WD, Jr., Brenz R, McGrath CM, Russo J, Pauley RJ, Jones RF, Brooks SC. 1990. Isolation and characterization of a spontaneously immortalized human breast epithelial cell line, MCF-10. Cancer Res 50:6075-6086.
39. Strick R, Strissel PL, Borgers S, Smith SL, Rowley JD. 2000. Dietary bioflavonoids induce cleavage in the MLL gene and may contribute to infant leukemia. Proc Natl Acad Sci USA 97:4790-4795.
40. Takai D, Jones PA. 2003. The CpG island searcher: A new WWW resource. In Silico Biol 3:235-240.
41. Tschop K, Engeland K. 2007. Cell cycle-dependent transcription of cyclin B2 is influenced by DNA methylation but is independent of methylation in the CDE and CHR elements. FEBS J 274:5235-5249.
42. Vulcain E, Goupy P, Caris-Veyrat C, Dangles O. 2005. Inhibition of the metmyoglobin-induced peroxidation of linoleic acid by dietary antioxidants: Action in the aqueous versus lipid phase. Free Radic Res 39:547-563.
43. Wenzel U, Kuntz S, Brendel MD, Daniel H. 2000. Dietary flavone is a potent apoptosis inducer in human colon carcinoma cells. Cancer Res 60:3823-3831.
44. Yang JH, Hsia TC, Kuo HM, Chao PD, Chou CC, Wei YH, Chung JG. 2006. Inhibition of lung cancer cell growth by quercetin glucuronides via G2/M arrest and induction of apoptosis. Drug Metab Dispos 34:296-304.
45. Yoshizumi M, Tsuchiya K, Kirima K, Kyaw M, Suzaki Y, Tamaki T. 2001. Quercetin inhibits Shc- and phosphatidylinositol 3-kinase-mediated c-Jun N-terminal kinase activation by angiotensin II in cultured rat aortic smooth muscle cells. Mol Pharmacol 60:656-665.
46. Yu JQ, Liu HB, Tian DZ, Liu YW, Lei JC, Zou GL. 2007. Changes in mitochondrial membrane potential and reactive oxygen species during wogonin-induced cell death in human hepatoma cells. Hepatol Res 37: 68-76.